Please complete security verification This request seems a bit unusual, so we need to confirm that you're human. Please press and hold the button until it turns completely green. Thank you for your cooperation! Press and hold the button If you believe this is an error, please contact our support team. 185.149.70.50 : d1389e61-b1d3-4b8d-977d-0bec7356
Share on PinterestA new study looks at how many people are admitted for COVID-19 treatment only after a second emergency room visit.The COVID-19 pandemic is one of the greatest challenges that the global healthcare system has recently faced — the workforce has been spread thin, and many countries have reported shortages of beds in intensive…
live updates on the current COVID-19 outbreak and visit our coronavirus hub for more advice on prevention and treatment.The team of researchers, led by Marien Hospital Herne and Ruhr-Universität Bochum in Herne, Germany, compared the T cell responses of 28 COVID-19 patients during the acute phase of the infection and after recovery in survivors. Of…
Coronavirus tests: which one should you take?New coronavirus tests are being developed every day. The Trump administration just ordered 150 million rapid antigen tests from Abbott Laboratories, but how do they stack up against other tests like the Polymerase chain reaction (PCR) test? Top infectious disease doctors from Harvard and Johns Hopkins break down the…
While lung scarring, heart and kidney damage may result from COVID-19, doctors and researchers are starting to clock the potential long-term impact of the virus on the brain also. And many “long-haulers,” or COVID-19 patients who have continued showing symptoms for months after the initial infection passed, report neurological problems such as confusion and difficulty…
6 min read Long gone are the days when cheating was as easy to spot as a lipstick smudge on a shirt collar. In 2026, infidelity often takes the smaller, yet nonetheless shitty, form of “microcheating.” It could be a borderline flirty text to a colleague or check-ins with an old “friend” that start out
You don't have permission to access "http://www.medpagetoday.com/transplantation/hearttransplantation/119412" on this server. Reference #18.8a1c1602.1768366940.7e14c81d https://errors.edgesuite.net/18.8a1c1602.1768366940.7e14c81d
4 min read A new study found people lost an average of 32.4 pounds while on semaglutide and tirzepatide. People who discontinue GLP-1 drugs regained nearly 22 pounds within a year. They returned to their starting weight in less than 2 years. Doctors say there's three common mistakes people make that is likely contributing to